Studies on Tryptophan Metabolism in Male Subjects Treated with Hydrocortisone1
Hans Wolf, Raymond R. Brown
Abstract
Hans Wolf, Raymond R. Brown
Abstract
The influence of hydrocortisone on urinary excretion of metabolites of the kynurenine pathway of tryptophan metabolism has been studied in male subjects. Hydrocortisone caused increased urinary excretion of tryptophan metabolites (i.e., kynurenine, acetylkynurenine, kynurenic acid, 3-hydroxykynurenine, and xanthurenic acid) after a loading dose of 2 g l-tryptophan, whereas urinary excretion of anthranilic acid metabolites was unchanged. The conversion of tryptophan to nicotinic acid metabolites was inhibited. Vitamin B6 supplementation normalized urinary excretion of tryptophan metabolites and caused an increase in urinary excretion of anthranilic acid metabolites. These results indicate that the capacity of the kynurenine pathway is exceeded by a loading dose of 2 g l-tryptophan when tryptophan pyrrolase, the first step of the kynurenine pathway, is induced by hydrocortisone. On the other hand, hydrocortisone seems to inhibit the extent to which tryptophan enters the NAD pathway.
OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The influence of hydrocortisone on urinary excretion of metabolites of the kynurenine pathway of tryptophan metabolism has been studied in male subjects. Hydrocortisone caused increased urinary excretion of tryptophan metabolites (i.e., kynurenine, acetylkynurenine, kynurenic acid, 3-hydroxykynurenine, and xanthurenic acid) after a loading dose of 2 g l-tryptophan, whereas urinary excretion of anthranilic acid metabolites was unchanged. The conversion of tryptophan to nicotinic acid metabolites was inhibited. Vitamin B6 supplementation normalized urinary excretion of tryptophan metabolites and caused an increase in urinary excretion of anthranilic acid metabolites. These results indicate that the capacity of the kynurenine pathway is exceeded by a loading dose of 2 g l-tryptophan when tryptophan pyrrolase, the first step of the kynurenine pathway, is induced by hydrocortisone. On the other hand, hydrocortisone seems to inhibit the extent to which tryptophan enters the NAD pathway.
Key concepts: Xanthurenic acid, Anthranilic acid, Tryptophan, Kynurenic acid, Kynurenine, Excretion, Endocrinology, Internal medicine